This week's View goes over key points from a viewpoint on coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers, an article on recommendations for the management of acute myocardial infarction during the COVID-19 outbreak, and a perspective from the Editor-in-Chief of the Chinese Journal of Cardiology about initial COVID-19 affecting cardiac patients in China.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Cardiac Surgery, Cardiovascular Care Team, COVID-19 Hub, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, ACS and Cardiac Biomarkers, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and ACS, Interventions and Imaging, Angiography, Computed Tomography, Echocardiography/Ultrasound, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Acute Coronary Syndrome, Angiotensin II, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Cardiology Interventions, Cardiac Catheterization, Coronavirus, Coronavirus Infections, COVID-19, C-Reactive Protein, Critical Illness, Diabetes Mellitus, Diagnostic Imaging, Echocardiography, Electrocardiography, Heart Diseases, Heart Failure, Hospital Mortality, Hypertension, Losartan, Mechanical Thrombolysis, Myocardial Infarction, Natriuretic Peptide, Brain, Pandemics, Peptidyl-Dipeptidase A, Primary Prevention, Radiography, Renin-Angiotensin System, Reperfusion, Respiratory Distress Syndrome, Risk Assessment, SARS Virus, Secondary Prevention, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome, Tomography, X-Ray Computed, Troponin, Vascular Diseases, Vasoconstriction, Angiography, Coronary Angiography

< Back to Listings